Skip to content

Clinical trials

Phase 3 Heart Failure trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 3 Country / region: New Zealand Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20141
20173
20182
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lexicon Pharmaceuticals2
American Regent, Inc.1
Bayer1
CSL Behring1
Cytokinetics1
Scios, Inc.1
University of Alberta1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure8
Diabetes Mellitus, Type 22
Acute Coronary Syndrome1
Anemia, Iron-Deficiency1
Atherosclerosis1
Atrial Fibrillation1
Cardiovascular Diseases1
Coronary Artery Disease1
Dyspnea1
Heart Diseases1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.